公司概覽
業務類別 --
業務概覽 Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
公司地址 Brunnmattstrasse 6, Burgdorf, CHE, 3401
電話號碼 +41 344244111
傳真號碼 +41 344244122
公司網頁 https://www.ypsomed.com
員工數量 2099
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Simon Michel Director and Chief Executive Officer -- 19/05/2026
 
董事會成員
董事會 職務 更新日期
Dr. Martin Munchbach, PhD Director 19/05/2026
Mr. Simon Michel Director and Chief Executive Officer 19/05/2026
Mr. Paul Fonteyne, M.S. Vice Chairman of the Board 19/05/2026
Mr. Gilbert Achermann Chairman of the Board 19/05/2026
Ms. Marie-Pierre Zerr Director 19/05/2026
 
所屬ETF (更新日期: 18/07/2026 04:09)
代號 名稱 佔比% 持有日期
IEFAiShares Core MSCI EAFE ETF0.27%30/06/2026
AVDVAvantis International Small Cap Val ETF0.18%30/06/2026
SCZiShares MSCI EAFE Small-Cap ETF0.12%30/06/2026
IXUSiShares Core MSCI Total Intl Stk ETF0.07%30/06/2026
SCHCSchwab International Small-Cap Eq ETF™0.06%30/06/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.